Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIKfyve is a lipid kinase that phosphorylates phosphatidylinositol 3-phosphate (PtdIns3P) to generate phosphatidylinositol 3,5-bisphosphate [PI(3,5)P₂]. It also plays a role in the production of phosphatidylinositol 5-phosphate [PI(5)P]. These phosphoinositides are critical regulators of endosome–lysosome–autophagy signaling pathways and vesicular trafficking. PIKfyve dysfunction is linked to defects in vesicle trafficking/endolysosomal system and is implicated in neurodegenerative disorders, several cancers, and viral entry.
Inhibition of PIKfyve kinase activity, disrupting TLR signaling and endolysosomal pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide kinase, FYVE-type zinc finger containing (PIKFYVE).